(Q44031728)

English

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study (English)

1 reference

Europe PubMed Central

29 November 2017

0 references

0 references

chronic obstructive pulmonary disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Keith L Hattotuwa

1

1 reference

Europe PubMed Central

29 November 2017

Mariusz J Gizycki

2

1 reference

Europe PubMed Central

29 November 2017

Tareq W Ansari

3

1 reference

Europe PubMed Central

29 November 2017

Peter K Jeffery

4

1 reference

Europe PubMed Central

29 November 2017

Neil C Barnes

5

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

29 November 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

29 November 2017

165

1 reference

Europe PubMed Central

29 November 2017

1592-1596

1 reference

Europe PubMed Central

29 November 2017

12

1 reference

Europe PubMed Central

29 November 2017

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Bronchial responsiveness, lung mechanics, gas transfer, and corticosteroid response in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Some histological changes in chronic bronchitis and asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: correlation with chronicity of the lesion

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Allergic respiratory disease: strategic targets for primary prevention during childhood.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105025

21 January 2018

Identifiers

10.1164/RCCM.2105025

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44031728&oldid=2105797446"